Submit your Defective Drugs claim details for a free, no obligation case review.
Get Started:
drug_recall risperdalRisperdal medication is classified as an antipsychotic approved only to treat symptoms of schizophrenia. Made by Johnson & Johnson, Risperdal medication created $2.1 billion in annual global sales. The introduction of Risperdal medication was viewed as a newer, more powerful drug with few side effects. Over ten million people worldwide have used Risperdal medication, making Risperdal medication the number one prescribed antipsychotic drug.
On April 10, 2003, J&J announced letters would be sent out to thousands of U.S. doctors to warn of the increased risk of stroke or stroke-like events in elderly Risperdal medication patients. In addition, J&J said that the package insert Risperdal medication label would reflect the possibility of suffering serious Risperdal medication adverse effects as well.
Canadian doctors had already received Risperdal medication warnings in
October 2002. At this time, J&J cited 37 reports of Risperdal stroke
or stroke-like events, including 16 deaths. Some patients that have suffered
Risperdal medication adverse effects have wondered why a Canadian Risperdal
medication warning was issued so much earlier than in the U.S.
Janssen Pharmaceutic Products, the makers of the anti-psychotic drug Risperdal, sent a letter to the health care community outlining the potential health risks associated with the medication.
This action is in compliance with the FDA''s re...
According to new data, once an effective dose has been reached Zyprexa and Risperdal have been shown to have inferior results in terms of anti-aggressive effects compared to cl...